ANI PHARMACEUTICALS INC — Director's Dealing 2019

Mar 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2019-03-12

Reporting Person: Schrepfer Robert W (SVP - New Bus Dev & Spec Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-12	Common Stock	M	5642	$28.76	Acquired	53484	Direct
2019-03-12	Common Stock	S	5642	$64.4414	Disposed	47842	Direct
2019-03-12	Common Stock	M	1503	$33.00	Acquired	49345	Direct
2019-03-12	Common Stock	S	1503	$64.50	Disposed	47842	Direct
2019-03-13	Common Stock	M	4651	$33.00	Acquired	52493	Direct
2019-03-13	Common Stock	S	4651	$64.4261	Disposed	47842	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-12	Option to Purchase	$28.76	M	5642	Disposed	2024-08-19	Common Stock ()	Direct
2019-03-12	Option to Purchase	$33.00	M	1503	Disposed	2024-03-31	Common Stock (1503)	Direct
2019-03-13	Option to Purchase	$33.00	M	4651	Disposed	2024-03-31	Common Stock (4651)	Direct

Footnotes

F1: Option vests and are exercisable over a four year period beginning on the first anniversary of the August 20, 2014.

F2: Option vests and are exercisable over a four year period beginning on the first anniversary of the April 1, 2014.